Search

everythinglearnresearchcommunity

for

Search:↓

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

The HoVert technique is a simple, cost-effective new method that improves alopecia diagnosis by allowing detailed analysis from a single biopsy.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

Widened sweat ducts are a very specific sign of scarring hair loss.

Platelet-Rich Plasma (PRP) can improve hair loss in cicatricial alopecia cases, but treatment must be ongoing and results vary among patients.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.

Isotretinoin was not effective in treating facial lichen planopilaris.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

The link between pemphigus and the patient's scarring hair loss is still unclear.

Hair transplantation is safe and effective for permanent hair loss due to scarring, with high patient satisfaction.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Traction may not be the only cause of cicatricial marginal alopecia.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

A positive anagen pull test can help detect active Lichen Planopilaris.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Oral minoxidil can increase or maintain hair thickness in most people with lichen planopilaris, with mild side effects.